Should I Keep Taking Metformin With Ozempic?

Last reviewed: June 28, 2026

Last updated: June 28, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Semaglutide and metformin target different pathways in glucose regulation and weight management, meaning they often work synergistically rather than against each other. According to clinical practice guidelines, combining a GLP-1 receptor agonist like semaglutide with metformin is generally considered safe and may enhance metabolic benefits. However, your individual situation—including kidney function, current dosing, and treatment goals—determines whether continuing both medications makes sense for you.

How Semaglutide and Metformin Work Together

Semaglutide acts as a GLP-1 receptor agonist, slowing stomach emptying, reducing appetite, and improving insulin secretion in response to meals. Metformin, by contrast, decreases glucose production in the liver and improves insulin sensitivity in muscle and fat cells. Because they operate through distinct mechanisms, combining them often produces additive benefits for blood sugar control and weight reduction.

Clinical trials have demonstrated that GLP-1 agonists paired with metformin achieve greater reductions in hemoglobin A1C and body weight compared to either drug alone. Patients using semaglutide injections alongside metformin frequently experience more stable blood sugar levels throughout the day and sustained weight loss over 12–24 months. This complementary approach is why many endocrinologists recommend maintaining metformin when initiating semaglutide therapy.

Safety Considerations When Combining Both Medications

The combination of semaglutide and metformin has not been associated with major drug-drug interactions in clinical practice or pharmacological studies. Both medications are processed through different organ systems, reducing the likelihood of competition for metabolism or clearance. However, certain individual factors—such as reduced kidney function, dehydration risk, or gastrointestinal sensitivity—may influence whether your healthcare provider recommends adjustments to either dose.

Metformin carries a rare but serious risk called lactic acidosis, which becomes more concerning if kidney function declines. Semaglutide can cause nausea and reduced appetite, which might lower your caloric intake enough to require a decrease in metformin dosing if blood sugar drops too low. Regular monitoring of kidney function, electrolytes, and glucose levels helps your provider catch any complications early and adjust treatment as needed.

When Your Doctor May Recommend Stopping Metformin

If semaglutide therapy produces such substantial weight loss and blood sugar improvement that your fasting glucose falls consistently below target ranges, your healthcare provider may lower or discontinue metformin to prevent hypoglycemia (dangerously low blood sugar). Similarly, if kidney function declines during treatment—whether due to dehydration, illness, or age-related changes—metformin may need to be stopped because the kidneys cannot safely clear the medication. A creatinine or eGFR test at baseline and periodically during treatment helps determine whether metformin remains appropriate.

Some patients experience persistent gastrointestinal side effects from metformin (bloating, diarrhea) that worsen when combined with semaglutide's appetite-suppressing effects. In these cases, switching to a different glucose-lowering agent or stopping metformin altogether may improve tolerability. The decision always rests with your prescribing doctor based on lab results, symptom burden, and your individual metabolic response.

Personalizing Your Medication Plan With PlexusDx

PlexusDx offers compounded semaglutide injections starting at $149 per month through licensed 503A compounding pharmacies, with no insurance required and HSA/FSA eligibility available. When you begin semaglutide therapy with PlexusDx, your provider can monitor your response over several months and make evidence-based decisions about whether metformin should continue, be reduced, or be replaced with an alternative agent.

PlexusDx also offers the Precision Peptide Genetic Test ($99 add-on after your first month of treatment), which maps 14 metabolic pathways and 49 peptides to reveal genetic variations affecting how your body responds to GLP-1 medications and other weight-loss compounds. Understanding your genetic predispositions—such as variants in GLP1R, GIPR, and FTO genes—empowers your healthcare team to personalize not only your semaglutide dose but also your complete medication regimen, including decisions about continuing metformin. This precision approach maximizes efficacy while minimizing unnecessary medications.

How Your Genetics Influence GLP-1 Response

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Frequently Asked Questions

Is it safe to take metformin and semaglutide together?

Yes, semaglutide and metformin are safe to use together because they work through different mechanisms and do not have significant drug-drug interactions. However, your healthcare provider should monitor your kidney function and blood sugar levels regularly, as semaglutide's effects may eventually require adjustments to metformin dosing.

Will semaglutide make metformin less effective?

No, semaglutide does not reduce metformin's effectiveness. Instead, the two medications often complement each other—metformin improves insulin sensitivity while semaglutide enhances insulin secretion and reduces appetite, leading to greater combined benefits for blood sugar control and weight loss.

Can I start semaglutide from PlexusDx while taking metformin?

Yes, you can start PlexusDx compounded semaglutide injections (starting at $149 per month) while continuing metformin. Your provider will assess your baseline kidney function and glucose levels, then monitor your progress to determine whether any medication adjustments are needed over time.

What are the side effects of combining these medications?

The combination typically produces side effects from semaglutide (nausea, reduced appetite, constipation) rather than new interactions with metformin. If gastrointestinal symptoms worsen, your doctor may adjust doses or consider alternatives to either medication based on your individual tolerance.

How does PlexusDx's genetic test help decide whether to keep metformin?

PlexusDx's Precision Peptide Genetic Test ($99 after your first month) identifies variants in genes like GLP1R, GIPR, and FTO that predict your response to semaglutide and other weight-loss compounds. This genetic insight helps your provider anticipate how aggressively your metabolism will improve, informing whether metformin should be continued, reduced, or replaced for optimal safety and results.

Related Reading

• Lifemd Ozempic
• Eden Ozempic
• Ro Ozempic
• Mochi Ozempic

Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.